Raju Prasad, Chief Financial Officer at CRISPR Therapeutics AG (CRSP), sold 7,048 shares at $72.69 ($512K) on 2024-03-15, disclosed to the SEC on 2024-03-18.
Open-market sale of $512k CRSP by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $72.69 | 3,524 | $256K | 50.0% |
| 2 | $72.69 | 3,524 | $256K | 50.0% |
| Total | $72.69 avg | 7,048 | $512K | 100% |
| Filing → |
| CRSP | SELL | 2026-01-26 | $2.1M | — | Filing → |
| CRSP | SELL | 2026-01-08 | $3.3M | — | Filing → |
| CRSP | SELL | 2025-12-23 | $1.1M | — | Filing → |